Navigation Links
Asthma 'Rescue' Inhalers Are Changing
Date:11/10/2008

eople need to be aware of. They include:

  • Priming. When you first use an inhaler, or if you haven't used it in awhile, you need to "prime" the pump to ensure that you're getting the accurate dose of medication. Priming entails spraying a dose or doses into the air, and priming requirements are different for each inhaler. Ask your pharmacist or check the package insert for your inhaler's priming requirements.
  • Inhaling. The spray from HFA inhalers doesn't come out as forcefully, and some people have reported feeling as if they're not getting enough medication. "A lot of people who say the inhalers aren't working may not be using proper inhalation technique," said Nancy Sander, president of the Allergy and Asthma Network Mothers of Asthmatics. "It's your inhalation that carries your medicine where it needs to go. So, start to breathe in as you press the inhaler." For more detailed instructions on the proper technique for using an inhaler, ask your doctor or pharmacist, or check the package insert, which also has instructions for using the inhaler.
  • Cleaning.HFA inhalers need to be cleaned more often than CFC inhalers. "HFAs are a little more sticky and tend to accumulate. If you see white powder in your inhaler, that's a dirty inhaler," said Sander. Finegold said all you need to do to clean the inhaler is rinse it in warm water and let it dry out overnight.
  • Cost. Because pharmaceutical companies had to come up with new ways to deliver old medications, there are no longer generic versions of albuterol inhalers available. That means you may pay more. Sander said she's heard that people who were paying $4 for a generic inhaler are now paying as much as $35 to $60 for their inhalers. She said that manufacturers have set up a coupon program to help offset some of the cost difference, but most people aren't aware of this program. Check with your doctor or directly with the manufacturer of you
    '/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Genetic predisposition increases childhood asthma risk
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Asthma Guidelines Stress Disease Control
4. Study finds some kids are being misdiagnosed with asthma
5. Childhood asthma still inappropriately treated in the UK
6. Parents perceptions can hamper kids asthma care, study finds
7. Clean to Ease Allergy and Asthma Symptoms
8. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
9. Parents Worries Hamper Kids Asthma Treatment
10. School is Cool for Asthma Patients of All Ages
11. Mold linked to asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... The American Association of Homes and Services for the Aging ... Living and Supportive Services (CLASS) provisions remain in the final ... providing support to elders, people with disabilities and their caregivers. ... care reform bill that will make it affordable to care ...
(Date:12/4/2009)... While Congress debates whether health care reform ... point to 45 hospitals that lead through example ... nation while attaining the highest levels of efficiency. ... have been named 2009 Leapfrog Top Hospitals, based ...
(Date:12/4/2009)... Western Reserve University researchers, from the School of Medicine,s ... which products of lipid peroxidation and some drugs of ... identified by a combination of metabolomics and mass isotopomer ... of action of the drug of abuse gamma-hydroxybutyrate, also ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... the pharmaceutical Antifoam (Simethicone) business from Bluestar Silicones. , ... ... -- NuSil Technology ( http://www.nusil.com ), a leading formulator and ... announced a definitive agreement to acquire the pharmaceutical Antifoam (Simethicone) ...
... Sleep apnea has long been known to be associated with ... issue of Diabetes Care finds that the disorder ... nearly 87 percent of participants reported symptoms, but were ... doesn,t just mean their sleep is disrupted; existing research shows ...
... following is a statement of Matthew L. Myers, ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) The Campaign for Tobacco-Free ... his leadership role in Senate committee approval of ... Administration (FDA) regulatory authority over tobacco products, including ...
... Smart Balance, Inc. (Nasdaq: SMBL ) today held ... and CEO Stephen Hughes spoke to stockholders about the Company,s ... past year, consumers have found Smart Balance,s brand proposition compelling ... category of spreads," Hughes said. "We are excited as ...
... communities in outstate Minnesota MINNEAPOLIS, May 20 ... regional grants dedicated to reducing tobacco,s harm through ... grants will provide resources to communities outside the ... our continuing commitment to reducing tobacco,s harm and ...
... the Archdiocese of Boston may soon refer women ... Centene Corp. and archdiocese-run Caritas Christi Health Care.(Logo: ... over the impact of nationalized health care on ... to ethically compromise with a potential federal health ...
Other Medicine News:Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 2Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 3Health News:More than a bad night's sleep 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 3Health News:ClearWay Minnesota(SM) Board Approves Four Regional Grants 2Health News:ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture 2
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
(Date:12/3/2009)... YORK, Dec. 3 Guidepoint Global, LLC , a ... Sleep Apnea Tracker, a monthly longitudinal data release that monitors ... Apnea market. ,, The Sleep Apnea Tracker captures actual ... in the United States from 15 different equipment providers going ...
(Date:12/3/2009)... Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ... innovative small molecule drugs for the treatment of immune ... host a webcast and conference call on, Tuesday, December ... and 8:00am Pacific Time) to discuss clinical data regarding ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Smart Balance Announces 2009 Second Quarter Results 53838 1Smart Balance Announces 2009 Second Quarter Results 53838 2Smart Balance Announces 2009 Second Quarter Results 53838 3Smart Balance Announces 2009 Second Quarter Results 53838 4Smart Balance Announces 2009 Second Quarter Results 53838 5Smart Balance Announces 2009 Second Quarter Results 53838 6Smart Balance Announces 2009 Second Quarter Results 53838 7Smart Balance Announces 2009 Second Quarter Results 53838 8Smart Balance Announces 2009 Second Quarter Results 53838 9Smart Balance Announces 2009 Second Quarter Results 53838 10Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 1Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 2Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti Infection Treatments 13413 3
... This Patient ... Population -, ... and Bristol-Myers Squibb Company (NYSE: BMY ),announced today that the ... for ABILIFY(R) (aripiprazole) for the,acute treatment of manic and mixed episodes ...
... 275 residents screened for HIV during three testing days ... of,February, Test for Life worked with the Washington Wizards, ... Washington, DC,to offer free and confidential HIV testing to ... at the Temple of Praise,Whitman-Walker and Us Helping Us ...
Other Medicine Technology:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 2U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 3U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 4U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 5U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 6U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 7U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 8U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age) 9Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS 2
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: